Open AccessRole of Cytokines and Vaccines in Break through COVID 19 Infections
Author(s) -
Ravindra Kumar,
Purabi Saha,
Richard Owusu Nyarko,
Ivan Kahwn,
Edward Amoah Boateng,
Paul Owusu Boateng,
Christian Asum,
Asare Bertram
Publication year - 2021
Publication title -
journal of pharmaceutical research international
Language(s) - English
Resource type - Journals
ISSN - 2456-9119
DOI - 10.9734/jpri/2021/v33i60b34912
Subject(s) - vaccination , covid-19 , immune system , immunity , immunology , medicine , virology , outbreak , disease , infectious disease (medical specialty) , pathology
Background: Despite efforts to develop a COVID-19 vaccine, it has failed to provide long-term immunity and protection against COVID-19 and the newly worrying SARS-CoV-2 coronavirus strains. Understanding cytokines, which are key in generating unique immune responses from pathogenic organisms, is important for creating vaccines.
Objective: In order to better understand cytokines and how the current COVID-19 vaccinations can assist reactivate latent cytokines, the scientific community and the general public must be educated.
Materials and Methods: Medical and scientific indexing sources like PubMed and Google Scholar were used to search for relevant medical and scientific publications.
Results: After vaccination, cytokines in the immune system can be activated, which can help signal chemicals that can increase the immune system's ability to fight against new and break-through COVID 19 infections.
Conclusion: It has been discovered that both the Pfizer-BioNTech and the Moderna vaccines are safe and effective in preventing break through COVID-19 infections, regardless of whether the patient experiences symptoms or not. It is an adenovirus, not an mRNA, that Johnson & Johnson's vaccine is made of.